Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis.

Luisa AgnelloMatteo VidaliRosaria Vincenza GiglioCaterina Maria GambinoAnna Maria CiaccioBruna Lo SassoMarcello Ciaccio

Published in: Clinical chemistry and laboratory medicine (2022)

PHI has a high accuracy for detecting PCa and discriminating between aggressive and non-aggressive PCa. Thus, it could be useful as a biomarker in predicting patients harbouring more aggressive cancer and guiding biopsy decisions.

Keyphrases

prostate cancer
end stage renal disease
newly diagnosed
ejection fraction
healthcare
chronic kidney disease
public health
mental health
prognostic factors
squamous cell carcinoma
young adults
ultrasound guided
patient reported outcomes
fine needle aspiration
human health
social media